Medicare Enrolled
Dr. Joseph Imsais, M.D.
Cardiovascular Disease · Austin, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Imsais from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Imsais? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Imsais
Dr. Joseph Imsais is a cardiovascular disease in Austin, TX, with 18 years in practice. Based on federal Medicare data, Dr. Imsais performed 3,156 Medicare services across 2,699 unique beneficiaries.
Between the years covered by Open Payments, Dr. Imsais received a total of $64,817 from 71 pharmaceutical and/or device companies across 809 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Imsais is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice▲ Top 32% volume in TX$ $64,817 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,156
Medicare services
Top 32% in TX for cardiovascular disease
2,699
Unique beneficiaries
$74
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~175 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 863 | $92 | $206 |
| Electrocardiogram (EKG), 12-lead | 701 | $11 | $60 |
| EKG interpretation and report | 251 | $6 | $27 |
| Office visit, established patient, complex (40-54 min) | 199 | $130 | $278 |
| Echocardiogram, transthoracic | 174 | $47 | $205 |
| New patient office visit (45-59 min) | 91 | $110 | $320 |
| Hospital follow-up visit, high complexity | 89 | $92 | $202 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 78 | $11 | $47 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 74 | $56 | $236 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 70 | $139 | $704 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 46 | $10 | $39 |
| Ultrasound of both sides of head and neck blood flow | 44 | $25 | $92 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 44 | $92 | $507 |
| Initial hospital admission, moderate complexity | 39 | $104 | $268 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 38 | $15 | $70 |
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 34 | $1,424 | $6,562 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 34 | $15 | $72 |
| Office visit, established patient (20-29 min) | 33 | $65 | $139 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 32 | $10 | $45 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 28 | $28 | $102 |
| Initial hospital admission, high complexity | 28 | $139 | $393 |
| Cardiac catheterization | 25 | $195 | $983 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 21 | $63 | $278 |
| Ultrasound of leg arteries or artery grafts | 21 | $26 | $88 |
| Ultrasound study of arm and leg arteries | 20 | $8 | $38 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 18 | $6 | $24 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 17 | $2 | $12 |
| New patient office visit, complex (60-74 min) | 17 | $146 | $398 |
| Ultrasonic guidance for needle placement | 16 | $46 | $592 |
| Ultrasound of heart, follow-up | 11 | $20 | $83 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.3% high complexity
14.4% medium
77.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$64,817
Total received (2018-2024)
Avg $9,260/year across 7 years
Top 9% in TX for cardiovascular disease
71
Companies
809
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$32,310 (49.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$22,219 (34.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$10,288 (15.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$7,689
2023$13,430
2022$15,595
2021$9,484
2020$2,789
2019$7,395
2018$8,435
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Bolton Medical Inc
$28,854
Penumbra, Inc.
$6,527
Endologix, Inc.
$5,363
ABIOMED
$2,830
Philips Electronics North America Corporation
$2,400
Medtronic Vascular, Inc.
$2,154
Abbott Laboratories
$1,598
Amgen Inc.
$1,204
ShockWave Medical, Inc
$1,173
AngioDynamics, Inc.
$917
Shockwave Medical, Inc
$898
Novartis Pharmaceuticals Corporation
$890
Endologix LLC
$752
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$736
CARDIVA MEDICAL, INC.
$641
AstraZeneca Pharmaceuticals LP
$568
Janssen Pharmaceuticals, Inc
$501
Amarin Pharma Inc.
$494
Veryan Medical Incorporated
$469
PFIZER INC.
$469
Endologix, LLC
$456
E.R. Squibb & Sons, L.L.C.
$428
Cook Medical LLC
$341
Medtronic, Inc.
$316
CeloNova BioSciences, Inc.
$280
Smith+Nephew, Inc.
$240
Teleflex LLC
$227
Regeneron Healthcare Solutions, Inc.
$220
Boehringer Ingelheim Pharmaceuticals, Inc.
$207
Impulse Dynamics (USA) Inc.
$202
Inspire Medical Systems, Inc.
$188
Lexicon Pharmaceuticals, Inc.
$158
W. L. Gore & Associates, Inc.
$141
iRhythm Technologies, Inc.
$136
Cagent Vascular INC
$134
Boston Scientific Corporation
$133
SANOFI-AVENTIS U.S. LLC
$131
Philips North America LLC
$123
Tactile Systems Technology Inc
$105
Surmodics, Inc.
$93
Alnylam Pharmaceuticals Inc.
$90
Cardiovascular Systems Inc.
$89
Kowa Pharmaceuticals America, Inc.
$87
Esperion Therapeutics, Inc.
$83
Itamar Medical Inc
$63
Bayer HealthCare Pharmaceuticals Inc.
$58
Gilead Sciences, Inc.
$57
Edwards Lifesciences Corporation
$52
Cleerly, Inc.
$49
BIOTRONIK INC.
$49
Althera Pharmaceuticals LLC
$48
ASAHI INTECC USA, INC.
$46
Bardy Diagnostics, Inc.
$33
AGEPHA Pharma FZ LLC
$29
ARBOR PHARMACEUTICALS, INC.
$25
Baxter Healthcare
$24
Lantheus Medical Imaging, Inc.
$22
Otsuka America Pharmaceutical, Inc.
$21
LANTHEUS MEDICAL IMAGING, INC.
$21
Bayer Healthcare Pharmaceuticals Inc.
$19
Bard Peripheral Vascular, Inc.
$18
Acist Medical Systems, Inc.
$17
Biocompatibles, Inc.
$15
BOSTON SCIENTIFIC CORPORATION
$15
AMAG Pharmaceuticals, Inc.
$15
Inari Medical, Inc.
$14
EKOS Corporation
$13
Medicure Pharma Inc.
$11
Allergan Inc.
$11
Merck Sharp & Dohme Corporation
$11
CashFlow Solutions, LLC
$11
Top 3 companies account for 62.9% of total payments
Associated products mentioned in payments ›
(5027) Intact Vascular Undivided · (6536) Phoenix · (6554) Periph Vasc Undiv · (6554) Peripheral Vascular Undivided · (9282) Turbo Power · (9520) IGT Devices Undivided · (AM7) Stellarex · ACCESS · ACUFEX TRUNAV · AFX · AFX2 Bifurcated Endograft System · AMPLATZER · AMPLATZER Occluders · ASSURITY · AURYON LASER SYSTEM 100-120 VAC · Advisa · Alto Abdominal Stent Graft System · Amplia MRI · Assurity Pacemaker · Auryon Laser System 100-120 Vac · BRILINTA · BYSTOLIC · BioMimics 3D Vascular Stent System · CAMZYOS · CARDIOFORM Septal Occluder · CARDIVA VASCADE 6/7F VCS · CARDIVA VASCADE MVP VVCS 6-12F · CHANTIX · CLOSUREFAST · COBALT DR MRI SURESCAN · COREVALVE EVOLUT R · Carnation Ambulatory Monitor · Catheter - GuideLiner · Catheter - Turnpike · Cleerly Ischemia · ClosureFast · ClosureRFG · ClosureRFS · CoreValve Evolut · Corlanor · DEFINITY · DIAMONDBACK CORONARY · EKOSONIC · ELIQUIS · ENTRESTO · EVKEEZA · Edarbyclor · EkoSonic · FARXIGA · FERAHEME · FLEXITOUCH · FLOWTRIEVER CATHETER · Flexitouch Plus · Fox Sv PTA catheter and Armada 14 percutaneous catheter and Viatrac 14 Plus peripheral catheter · GENERAL - VASCULAR INTERVENTION · GLIDESHEATH SLENDER · GUARDIAN · GUIDELINER · Grafts · Hi-Torque Command guide wire · Hillrom - Carnation Ambulatory Monitor · IGT D Peripheral · IGT_D Peripheral · IN.PACT Admiral · INSPIRE · Image Guided Therapy Devices _ Peripheral · Impella · Indigo · Indigo System · Inpefa · JARDIANCE · JOT DX · Kerendia · LEQVIO · LODOCO · LYMPHA PRESS OPTIMAL PLUS(US) BT · Legacy · LifeVest · Livalo · MANTA · MANTA Vascular Closure Device · METACROSS OTW · MULTAQ · MyCareLink · NEXLETOL · NEXLIZET · ONPATTRO · OPTIMIZER · OPTIS · OPTOWIRE · Omnilink Elite vascular stent system · Optimizer · Ovation · PERIPHERAL VASCULAR · PK Papyrus · POD · PRALUENT · PROCLAIM · Penumbra System · Peripheral Orbital Atherectomy System · Pounce Thrombectomy System · RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM · ROSEN · RXi Systems · Relay Grafts · Relay Plus · Repatha · Resolute · Reveal LINQ · Revolution · Roszet · S · SAMSCA · SHOCKWAVE INTRAVASCULAR LITHOTRIPSY (IVL) SYSTEM WITH THE SHOCKWAVE C2+ CORONARY · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · Serrantor · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Smart Coil · Supera peripheral stent system · TREO ABDOMINAL STENT-GRAFT SYSTEM · VARITHENA · VERQUVO · VYNDAQEL · Varithena Administration Pack · Vascepa · Vascular Closure Device · Vascular Lithotripsy · VenaSeal · WatchPAT · XARELTO · Xience V coronary stent system · ZILVER PTX · ZILVER VENA · ZIO XT Patch · ZYPITAMAG
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (50%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for cardiovascular disease in TX.
Equivalent to $2,054 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
97
Per 100K population
7.4
County median income
$97,169
Nearest hospital
NORTH AUSTIN MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Imsais is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (mixed engagement, top 9%), with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Imsais experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Imsais performed 863 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Imsais receive payments from pharmaceutical companies?
Yes. Dr. Imsais received a total of $64,817 from 71 companies across 809 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Imsais's costs compare to other cardiovascular diseases in Austin?
Dr. Imsais's average Medicare payment per service is $74. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Imsais) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Austin
Browse cardiovascular diseases in Austin ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in TX
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in TX
Which TX cardiovascular diseases receive the most from drug and device companies.
By company
Bolton Medical Inc Payments to Doctors
See all physicians who received payments from Bolton Medical Inc.
By company
Penumbra, Inc. Payments to Doctors
See all physicians who received payments from Penumbra, Inc..
By company
Endologix, Inc. Payments to Doctors
See all physicians who received payments from Endologix, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology